UNSPSC 51282953: Enoxacin

This classification denotes an anti-infective agent with the molecular formula C15H17FN4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 325OGW249P, chemically known as 1,8-naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro- 4-oxo-7-piperazinyl but more generally known as enoxacin, which bears US NIH Compound Identifier 3229. European Medicines Agency schedules Enoxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06540MIG.

UNSPSC 51282953 Enoxacin, a Commodity code, nominally addresses a single antibiotic pharmaceutical, but recent state and local activity shows this code tagged to broader pharmaceutical and medical supply procurement — specifically naloxone (an opioid antagonist), generic multi-source pharmaceuticals, over-the-counter products, and emergency medical consumables. The work being solicited includes purchase of finished pharmaceuticals and medical supplies for health departments, fire rescue divisions, and state pharmacy benefit programs, with delivery to end-use facilities and distribution through authorized wholesalers. Issuing bodies span county health departments (Seminole County, Florida), municipal fire and rescue services (City of Tampa), state health agencies (Texas Health and Human Services Commission), and state cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance). The code appears to be applied loosely across pharmaceutical and medical supply categories rather than reserved for enoxacin specifically.

Recent activity is concentrated in Florida and Minnesota, with a significant exploratory procurement underway in Texas. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 drug deactivation systems annually for quarterly delivery to the county community health building, with a response date of July 26, 2023 (note: date conflict in source). The City of Tampa released IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies valued at approximately $700,000 for the fire department rescue division, with a March 13, 2026 response deadline and a 5 percent Small Local Business Enterprise set-aside with a $10,000 discount cap. The Minnesota Department of Administration issued RFP S1070000015802 through MMCAP on January 20, 2026, for generic multi-source pharmaceuticals and OTC products to be distributed across state and local government facilities in Minnesota and Oregon, with proposals due March 26, 2026, and award contingent on availability by May 15, 2026. Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, as an exploratory market-intelligence phase for a direct-to-manufacturer pharmacy initiative, with no formal evaluation criteria or award values specified.